Atlas Trials

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

Clinical trial NCT07674654 · RECRUITING

Trial details

NCT number
NCT07674654
Sponsor
Kallyope Inc.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Migraine
Start date
2026-08-03
Primary completion
2028-06-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.